DE68925365D1 - PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG - Google Patents

PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG

Info

Publication number
DE68925365D1
DE68925365D1 DE68925365T DE68925365T DE68925365D1 DE 68925365 D1 DE68925365 D1 DE 68925365D1 DE 68925365 T DE68925365 T DE 68925365T DE 68925365 T DE68925365 T DE 68925365T DE 68925365 D1 DE68925365 D1 DE 68925365D1
Authority
DE
Germany
Prior art keywords
peptides
beta
ifn
antibodies
against antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925365T
Other languages
English (en)
Other versions
DE68925365T2 (de
Inventor
Paul Hoeprich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Publication of DE68925365D1 publication Critical patent/DE68925365D1/de
Application granted granted Critical
Publication of DE68925365T2 publication Critical patent/DE68925365T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE68925365T 1988-10-14 1989-10-04 PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG Expired - Fee Related DE68925365T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25765188A 1988-10-14 1988-10-14
PCT/US1989/004334 WO1990003982A1 (en) 1988-10-14 1989-10-04 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof

Publications (2)

Publication Number Publication Date
DE68925365D1 true DE68925365D1 (de) 1996-02-15
DE68925365T2 DE68925365T2 (de) 1996-09-12

Family

ID=22977172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925365T Expired - Fee Related DE68925365T2 (de) 1988-10-14 1989-10-04 PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG

Country Status (7)

Country Link
US (1) US5869603A (de)
EP (1) EP0440686B1 (de)
JP (1) JP2717319B2 (de)
AT (1) ATE132502T1 (de)
CA (1) CA2000420C (de)
DE (1) DE68925365T2 (de)
WO (1) WO1990003982A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7272636B2 (en) * 2001-04-24 2007-09-18 Sun Microsystems, Inc. Peer group name server
JP2005029471A (ja) * 2001-06-26 2005-02-03 Toray Ind Inc ペプチドの立体構造モチーフおよび３次元構造座標ならびにそれらの使用
US20040086874A1 (en) * 2002-10-31 2004-05-06 Parker Russell A. Devices and methods for holding a biopolymeric array
MX2018013222A (es) * 2016-04-29 2019-04-22 Pfizer Anticuerpos de interferon beta y usos de los mismos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties

Also Published As

Publication number Publication date
CA2000420C (en) 2000-12-19
EP0440686B1 (de) 1996-01-03
JPH07508494A (ja) 1995-09-21
CA2000420A1 (en) 1990-04-14
JP2717319B2 (ja) 1998-02-18
EP0440686A1 (de) 1991-08-14
ATE132502T1 (de) 1996-01-15
WO1990003982A1 (en) 1990-04-19
US5869603A (en) 1999-02-09
DE68925365T2 (de) 1996-09-12

Similar Documents

Publication Publication Date Title
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
ATE207080T1 (de) Multivalente antigen-bindende proteine
EP0724651A4 (de) Synthetische humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch
TR199800327T1 (en) A�ilaminosalisilamidler.
DE69429095T2 (de) Humanisierte antikoerper
IL130190A0 (en) Methods and compositions for polypeptide engineering
GEP20105118B (en) Anti-vegf antibodies
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ATE425251T1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
DE69128273T2 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE69319909D1 (de) Peptide für die Diagnose von und die Immunisierung gegen T.Cruzi-Infektionen
ATE120233T1 (de) Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
DE68925365T2 (de) PEPTIDE, DIE EPITOPE AUF R-IFN-BETA REPRÄSENTIEREN, ANTIKöRPER DAGEGEN, UND IHRE ANWENDUNG
AR248425A1 (es) Plasmidos pd143 y pd148 y vectores que contienen dichos plasmidos, cepa de saccharomyces cerevisiae, de lactococcal lactis y de e. coli ncimb 40217.
GB1531176A (en) Hydrogenated imidazothiazine derivatives
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
FR3628M (fr) Sulfates d'amylopectines, utiles comme inhibiteurs de pepsine et agents antiulcéreux.
ES2115975T3 (es) Derivados de triariletileno utilizados terapeuticamente.
TR200003608T2 (tr) Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri.
ITRM920223A0 (it) Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf.
ES1020042Y (es) Tijera de ropa perfeccionada.
ITTO911003A0 (it) Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.
FR2707090B1 (fr) Famille de Peptides, appelés Xénoxinés.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee